Qihuang Jianpi Zishen Granules improves renal damage in MRL/lpr mice by inhibiting B cell differentiation via the AIM2/Blimp-1/Bcl-6 axis.
10.12122/j.issn.1673-4254.2025.11.02
- Author:
Lili CHENG
1
;
Zhongfu TANG
1
;
Ming LI
1
;
Junjie CHEN
2
;
Shuangshuang SHANG
1
;
Sidi LIU
1
;
Chuanbing HUANG
1
Author Information
1. Department of Rheumatology, First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230012, China.
2. School of Traditional Chinese Medicine, Anhui University of Chinese Medicine, Hefei 230031, China.
- Publication Type:Journal Article
- Keywords:
AIM2/Blimp-1/Bcl-6;
B cells;
Qihuang Jianpi Zishen Granules;
renal damage;
systemic lupus erythematosus
- MeSH:
Animals;
Drugs, Chinese Herbal/therapeutic use*;
Mice, Inbred MRL lpr;
Female;
Mice;
Mice, Inbred C57BL;
Cell Differentiation/drug effects*;
B-Lymphocytes/drug effects*;
Proto-Oncogene Proteins c-bcl-6/metabolism*;
Kidney/drug effects*;
DNA-Binding Proteins/metabolism*;
Signal Transduction;
Lupus Nephritis
- From:
Journal of Southern Medical University
2025;45(11):2297-2308
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To investigate the efficacy of Qihuang Jianpi Zishen Granules (QJZ) for inhibiting renal B cell differentiation in MRL/lpr mice and explore its underlying mechanism.
METHODS:Thirty 8-week-old female MRL/lpr mice were randomly divided into model group, QJZ group, prednisone (Pred) group, QJZ+Pred group, and AIM2 inhibitor group (n=6), with 6 8-week-old female C57BL/6 mice as the normal control group. After treatments with normal saline, QJZ, Pred, or AIM2 inhibitor for 8 weeks, the mice were examined for urinary total protein-to-creatinine ratio (TPCR) and albumin-to-creatinine ratio (ACR), serum creatinine (Cr) and blood urea nitrogen (BUN) levels, and renal histopathology (with HE, Masson, and PAS staining) and ultrastructural changes (with electron microscopy). ELISA, immunohistochemistry, immunofluorescence staining and flow cytometry were used to detect blood levels of anti-dsDNA antibodies, cytokines and chemokines, renal deposition of complement components C3 and C4, renal expressions of AIM2, CD19, CD27 and CD138, and changes in splenic B lymphocyte subsets. The effect of QJZ on the AIM2/Blimp-1/Bcl-6 signaling axis was examined using Western blotting.
RESULTS:QJZ treatment significantly improved Cr, BUN, TPCR and ACR in MRL/lpr mice, ameliorated renal pathologies, reduced the expressions of ds-DNA, BAFF, IL-21, CXCL12, CXCL13, C3 and C4, and increased IL-10 levels. QJZ significantly downregulated renal expressions of the key B-cell transcription factors Blimp-1 and XBP-1, upregulated Bcl-6 and PAX5 expressions, inhibited B-cell differentiation, and lowered the expressions of AIM2, CD27, CD138 and CD69. Inhibition of AIM2 similarly reduced renal Blimp-1 and XBP-1 expressions, increased Bcl-6 and PAX5 levels, suppressed B-cell differentiation, decreased IgG production, reduced C3 and C4 deposition, and alleviated renal pathology in MRL/lpr mice.
CONCLUSIONS:QJZ inhibits B cell differentiation and alleviates renal damage in systemic lupus erythematosus possibly by suppressing the AIM2/Blimp-1/Bcl-6 signaling pathway.
